-
EZ Cap EGFP mRNA 5-moUTP Workflow Guide
2026-08-11
Use EZ Cap EGFP mRNA 5-moUTP as a reproducible fluorescent benchmark for mRNA delivery, translation, viability, and imaging workflows. Its Cap1 structure, 5-moUTP chemistry, and optimized poly(A) tail help separate delivery problems from intrinsic transcript-performance problems.
-
ddATP as a Causal Probe of DNA Replication
2026-08-11
ddATP, or 2',3'-dideoxyadenosine triphosphate, is more than a chain terminator nucleotide: it can help separate DNA synthesis from damage signaling. This article explains its chemistry, assay logic, and interpretation in replication and repair research.
-
REV1–DHX36 Control of G-Quadruplex Tolerance
2026-08-10
The reference study identifies a direct REV1–DHX36 partnership that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tier model explains how cells tolerate stabilized G-quadruplex DNA while linking replication stress to ATM/ATR signaling and potential cancer research applications.
-
KU-55933: Selective ATM Kinase Inhibitor
2026-08-09
KU-55933 is a potent and selective ATM kinase inhibitor for DNA damage response research and cancer research. Its reported biochemical potency, cellular effects on Akt signaling, and defined DMSO handling make it useful for mechanistic studies, but experimental concentrations should not be interpreted as clinical efficacy.
-
Antiepileptic Drugs and Human Aromatase Inhibition
2026-08-08
Jacobsen and colleagues evaluated 12 antiepileptic drugs in a human CYP19 aromatase assay and identified lamotrigine among the compounds capable of reducing enzyme activity. The study provides a useful comparative framework for investigating endocrine consequences of antiepileptic exposure, while also showing why recombinant enzyme findings should not be treated as direct evidence of clinical hormone disruption.
-
Baicalin Reactivates Adult Visual Plasticity
2026-08-07
A 2026 NeuroImage study reports that Baicalin reactivates ocular dominance plasticity in adult amblyopic mice, with recovery associated with reduced cortical GABAergic inhibition and perineuronal nets. The work provides a dose-sensitive, experimentally testable framework for combining pharmacological plasticity enhancement with reverse suturing, while leaving human translation and long-term durability unresolved.
-
CD28-ARS2 Axis Controls PKM Splicing and CD8+ T Cell Metabol
2026-08-07
This study identifies the CD28-ARS2 signaling axis as a pivotal regulator of alternative splicing in CD8+ T cells, promoting PKM2 expression and enabling metabolic flexibility for effective antitumor responses. These findings elucidate a distinct mechanism of immunometabolic adaptation, with implications for optimizing T cell-based therapies and metabolic assays.
-
AZD1390: ATM Kinase Inhibitor Workflows for Cancer Radiosens
2026-08-06
AZD1390 is transforming DNA damage response research by enabling precise inhibition of ATM kinase, facilitating radiosensitization in glioma and lung cancer models. This guide demystifies experimental workflows, practical troubleshooting, and protocol enhancements for researchers leveraging this next-generation ATM kinase inhibitor.
-
Innovations in In Vitro Methods for Evaluating Cancer Drug R
2026-08-06
Schwartz's dissertation introduces rigorous distinctions between proliferative arrest and cell death in evaluating anti-cancer drug responses in vitro, emphasizing the necessity of measuring both relative and fractional viability. This approach enhances the interpretability and predictive value of preclinical drug assessments, with direct relevance to topoisomerase 1 inhibitors like Topotecan HCl.
-
MEG3 Modulates NiO NP-Induced Pulmonary Fibrosis via PI3K/Ak
2026-08-05
The referenced study elucidates how lncRNA MEG3 counteracts nickel oxide nanoparticle-induced pulmonary fibrosis by inhibiting TGF-β1-mediated activation of the PI3K/Akt pathway in both rat lung tissue and human alveolar cells. These findings clarify the molecular interplay between noncoding RNA and critical signaling axes in nanoparticle toxicity, opening new avenues for targeted therapeutic research.
-
Applied Use-Cases of Olaparib (AZD2281) in DNA Repair Resear
2026-08-05
Olaparib (AZD2281) is redefining targeted cancer research by enabling precise DNA damage response assays and radiosensitization studies, especially in BRCA-mutant and homologous recombination-deficient models. This article translates the latest metabolic insights and protocol optimizations into actionable workflows, troubleshooting guidance, and future avenues for exploiting PARP inhibition.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Protocol & QC
2026-08-04
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables quantitative measurement of SOD enzyme activity in biological fluids, supporting the assessment of antioxidative capacity and oxidative stress in research samples. It is not designed for diagnostic or clinical applications and should be reserved for scientific research workflows requiring reproducible, colorimetric SOD activity detection.
-
ERAD-Hijacking Chimeras Enable Targeted Degradation of TM Pr
2026-08-04
Song et al. present a new platform, ERAD-engaging chimeras (ERADECs), that overcomes longstanding barriers in degrading transmembrane proteins by leveraging ER-associated degradation. This innovation expands the toolkit for selective protein removal and has significant implications for disease research and modulation.
-
Aromatase Inhibition by Lamotrigine and Other Antiepileptics
2026-08-03
This study systematically evaluates the potential of Lamotrigine and a panel of antiepileptic drugs to inhibit the human aromatase enzyme complex (CYP19) in vitro. The findings highlight both the diversity of AED effects on steroid hormone synthesis and the importance of considering off-target endocrine impacts when designing epilepsy research protocols.
-
REV1-DHX36 Interaction Facilitates G-Quadruplex DNA Replicat
2026-08-03
This study uncovers how human REV1 directly interacts with the G4 helicase DHX36 to promote replication and tolerance of G-quadruplex (G4) DNA structures. The findings reveal a two-tiered mechanism coordinating helicase activity and suppression of single-stranded DNA gaps, providing new mechanistic insight into genome stability and DNA damage response.